Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)

Q: What does CUSIP 761330109 represent in this 13F holders report?

CUSIP 761330109 is the security identifier for RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share in Q1 2018?

118 institutional investors reported RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share for Q1 2018. Use the holders table for investor-level position and value details.

CUSIP: 761330109

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 104,661,494
Total 13F shares: 34,209,499
Share change: -799,487
Total reported value: $1,053,625,660
Put/Call ratio: 45%
Price per share: $30.80
Number of holders: 118
Value change: -$35,231,819
Number of buys: 72
Number of sells: 41

Quarterly Holders Quick Answers

What is CUSIP 761330109?
CUSIP 761330109 identifies RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2018
Previous quarter: Q4 2017

Recent filing periods for CUSIP 761330109:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Essex Woodlands Management, Inc.	13F	Company	3.7%	3,842,047	$137,353,000	—	31 Dec 2017	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	3.4%	3,573,150	$127,740,000	—	31 Dec 2017	13F
JPMORGAN CHASE & CO	13F	Company	3.4%	3,557,979	$127,198,000	—	31 Dec 2017	13F
FRANKLIN RESOURCES INC	13F	Company	3.2%	3,394,202	$121,343,000	—	31 Dec 2017	13F
NovaQuest Capital Management, L.L.C.	13F	Company	3%	3,096,650	$110,705,000	—	31 Dec 2017	13F
BlackRock Finance, Inc.	13F	Company	2.1%	2,168,211	$77,513,000	—	31 Dec 2017	13F
Bank of New York Mellon Corp	13F	Company	2%	2,144,668	$76,672,000	—	31 Dec 2017	13F
ArrowMark Colorado Holdings LLC	13F	Company	1.7%	1,736,734	$62,088,000	—	31 Dec 2017	13F
VANGUARD GROUP INC	13F	Company	1.2%	1,240,603	$44,353,000	—	31 Dec 2017	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.1%	1,099,032	$39,290,000	—	31 Dec 2017	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.96%	1,000,000	$35,750,000	—	31 Dec 2017	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.87%	907,695	$32,450,000	—	31 Dec 2017	13F
JENNISON ASSOCIATES LLC	13F	Company	0.82%	857,536	$30,657,000	—	31 Dec 2017	13F
CANADA PENSION PLAN INVESTMENT BOARD	13F	Company	0.56%	582,900	$20,839,000	—	31 Dec 2017	13F
STATE STREET CORP	13F	Company	0.44%	461,360	$16,491,000	—	31 Dec 2017	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.38%	400,000	$14,300,000	—	31 Dec 2017	13F
NORTHERN TRUST CORP	13F	Company	0.29%	301,405	$10,774,000	—	31 Dec 2017	13F
GREAT POINT PARTNERS LLC	13F	Company	0.29%	300,000	$10,725,000	—	31 Dec 2017	13F
SENZAR ASSET MANAGEMENT, LLC	13F	Company	0.23%	236,355	$8,450,000	—	31 Dec 2017	13F
MORGAN STANLEY	13F	Company	0.22%	228,008	$8,151,000	—	31 Dec 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.21%	219,561	$7,849,000	—	31 Dec 2017	13F
FMR LLC	13F	Company	0.19%	201,600	$7,207,000	—	31 Dec 2017	13F
Rhenman & Partners Asset Management AB	13F	Company	0.17%	182,580	$6,527,000	—	31 Dec 2017	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.17%	180,105	$6,439,000	—	31 Dec 2017	13F
S.c.a. Candriam	13F	Individual	0.14%	151,000	$5,398,000	—	31 Dec 2017	13F
DEUTSCHE BANK AG\	13F	Company	0.12%	128,488	$4,592,000	—	31 Dec 2017	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.12%	126,180	$4,511,000	—	31 Dec 2017	13F
ESSEX INVESTMENT MANAGEMENT CO LLC	13F	Company	0.11%	118,952	$4,253,000	—	31 Dec 2017	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.11%	118,309	$4,230,000	—	31 Dec 2017	13F
Crawford Lake Capital Management, LLC	13F	Company	0.11%	117,666	$4,207,000	—	31 Dec 2017	13F
Nicholas Investment Partners, LP	13F	Company	0.11%	113,090	$4,043,000	—	31 Dec 2017	13F
Informed Momentum Co LLC	13F	Company	0.1%	107,333	$3,837,000	—	31 Dec 2017	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.09%	95,357	$3,409,000	—	31 Dec 2017	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.08%	87,956	$3,144,000	—	31 Dec 2017	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.08%	84,142	$3,008,000	—	31 Dec 2017	13F
UNITED SERVICES AUTOMOBILE ASSOCIATION	13F	Company	0.08%	78,560	$2,809,000	—	31 Dec 2017	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.07%	72,855	$2,605,000	—	31 Dec 2017	13F
QS Investors, LLC	13F	Company	0.07%	68,459	$2,447,000	—	31 Dec 2017	13F
Allianz Asset Management GmbH	13F	Company	0.07%	68,166	$2,437,000	—	31 Dec 2017	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.06%	64,614	$2,309,000	—	31 Dec 2017	13F
WADDELL & REED FINANCIAL INC	13F	Company	0.06%	63,900	$2,284,000	—	31 Dec 2017	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.06%	62,863	$2,247,000	—	31 Dec 2017	13F
A.R.T. Advisors, LLC	13F	Company	0.06%	62,100	$2,220,000	—	31 Dec 2017	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.05%	55,685	$1,991,000	—	31 Dec 2017	13F
Swiss National Bank	13F	Company	0.05%	51,650	$1,846,000	—	31 Dec 2017	13F
ROTHSCHILD & CO ASSET MANAGEMENT US INC.	13F	Company	0.05%	49,301	$1,763,000	—	31 Dec 2017	13F
Global IMC LLC	13F	Company	0.04%	44,898	$1,605,000	—	31 Dec 2017	13F
D. E. Shaw & Co., Inc.	13F	Company	0.04%	44,172	$1,579,000	—	31 Dec 2017	13F
TEACHERS ADVISORS, LLC	13F	Company	0.04%	42,535	$1,521,000	—	31 Dec 2017	13F
1492 Capital Management LLC	13F	Company	0.04%	38,966	$1,393,000	—	31 Dec 2017	13F

Institutional Holders of Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) as of Q1 2018

As of 31 Mar 2018, Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) was held by 118 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,209,499 shares. The largest 10 holders included Essex Woodlands Management, Inc., WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, FRANKLIN RESOURCES INC, BlackRock Inc., Bank of New York Mellon Corp, ArrowMark Colorado Holdings LLC, NovaQuest Capital Management, L.L.C., MILLENNIUM MANAGEMENT LLC, and JENNISON ASSOCIATES LLC. This page lists 118 institutional shareholders reporting positions in this security for the Q1 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2018 vs Q4 2017 Across Filers

Q4 2017 holders

115

Q1 2018 holders

118

Holder diff

Investor	Q4 2017 Shares	Q1 2018 Shares	Share Diff	Share Chg %	Q4 2017 Value $	Q1 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.